Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Summary of Pending Events "Not Mentioned" in RG SH letter #7

As someone has mentioned already, about the only thing that wasn't on your "not mentioned" list was the lack of another remark about,,,the inevitable IMO,,, reverse split

My comment........ is that it is coming, hopefully at a small ratio, but it is something that we will have to face, and I hope it's sooner than later. that would mean a hefty PPS gain to make the RS as small as possible.

Other than that, I would disagree with his sentence on dilution...

"We believe that the potential dilution (20%) will be offset by the ability to attract viable operating entities capable of increasing Patriot Scientifics market capitalization

Since we've been at around 400MM shares OS with 500 Mm authorized...this additional 100MM...when issued, which it will be IMO, will make the authorized rise by 20% for sure, but in my way of seeing it, we will have a ....50% increase in OS....from the recent 400MM to the now anticipated 600MM shares out there...

We definitely have some good possibilites going on, but we will see a 50% increaseof shares in the marketplace very soon, and that in turn will stifle PPS growth until we get a series of good Q's ....which of course will show EPS numbers lower than we would expect and even if the PE remains the same our projected PPS will be hurt some.

Our rev's/net earnings really needs to rise at a good rate now, if and when that occurs, our PPS will grow too, maybe not as much as we would like with all those shares out there, but it will climb when that net starts to show an "up and to the right" indication.

Share
New Message
Please login to post a reply